Drug Facts

Manufacturer
Henry Schein, Inc.
Effective date
2026-10-01
Label type
HUMAN OTC DRUG LABEL
Version
7
Source
daily-update
Hydrated at
2026-10-03 00:01:48

Label at a glance#

ProductHenry Schein Povidone-Iodine Prep Pad
Active ingredientPOVIDONE-IODINE
Label structure8 sections

Dosage and administration

Clean area. Apply to the operative site prior to surgery

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Povidone Iodine USP 10%

Purpose

OTC - PURPOSE SECTION

Antiseptic

Use

INDICATIONS & USAGE SECTION

For preparation of the skin prior to surgery

Warnings

WARNINGS SECTION

For external use only.

Do not apply to persons allergic to iodine.

Do not use in the eyes.

OTC - DO NOT USE SECTION

  • Ask a doctor before use if injuries are deep wounds, puncture wounds, serious burns.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

  • Keep out of reach of children
  • If swallowed or gets in eyes, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Clean area. Apply to the operative site prior to surgery

Other information

OTHER SAFETY INFORMATION

  • 1 % titratable iodine. Store at room temperature

Inactive ingredients

INACTIVE INGREDIENT SECTION

alkyl glucoside, citric acid, glycerin, hydroxyethyl cellulose, nonoxynol-10, potassium iodide, purified water, sodium hydroxide

Principal Display Panel - 0.5 mL Item Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

HENRY SCHEIN ® REF 570-1543

NDC 0404-0121-01

POVIDONE-IODINE PREP PAD

10% Povidone-Iodine

For Professional and Hospital Use

Do no re-use Not made with natural rubber latex Non-Sterile

1 Pad Per Pouch

Made in China

Distributed by:

Henry Schein Inc.

135 Duryea Road

Melville, NY 11747 USA

Rev. 2026/09

570-1543570-1543

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
e2db08c6-133f-4f4f-afb4-e90a2418d6f6Product name120230320
5f30b278-5791-4113-8781-878a9221ef8aProduct name220230125
ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906Product name720210625
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
2a70c781-a755-4d76-b20a-a958acfbdcdcProduct name220190619
11ed6f83-cdd2-4637-8379-b1a1d3ae3cdeProduct name120181101
304592ef-4a8a-4c22-8e8c-af73aa3d60e5Product name120180703
ac0821a1-ce75-4ea7-880a-59eecaecdf22Product name120180703
db5dc4f9-b907-46f6-8fb7-babcf04bbe5cProduct name120180619
86c45a79-b9f0-4476-a27c-6e10db098497Product name120180125
41e9d6cf-3ed7-4c44-a57e-0685058d0896Product name120170824
5e652c92-68fd-426b-b0e7-5fc64e0b9f99Product name120170309
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
ddc0c11a-bba8-408f-b3c7-c4828b4bcc8cProduct name120150421

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0404-01210404-0121-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
62026-09-08daily-update2026-09-11 03:01:23
52026-09-01daily-update2026-09-03 03:02:36
42026-08-25daily-update2026-08-28 00:02:02
32023-10-13full-release2026-05-31 23:56:44

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
5af825dd-93af-ad02-e063-6294a90a4998313416b8-60b2-4a77-9b56-5c507aae90722026-09-08WarningsExact identifier
spl set id: 313416b8-60b2-4a77-9b56-5c507aae9072

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.